Author Archives: katie carrera

Your couch is the new waiting room

In-Home Medical Appointment

The world of healthcare is always evolving, especially when it comes to digital health. Today, consumers want more options for staying on top of their health, and with the impacts of the COVID-19 pandemic, they have a strong need for more on-demand options. Life has changed in many ways over the last year with a […]

COVID-19 Testing Update: Delta Variant

Young Girl COVID

As you have probably seen in the news, genetic variants of SARS-CoV-2 have been emerging and circulating around the world throughout the COVID-19 pandemic. Most notable variants are the B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma) and B.1.617.2 (Delta) variants, which seem to spread more easily and quickly than other variants and may lead to more […]

SMA Awareness Month and the Importance of Carrier Screening

SMA Awareness Month Couple

This month, we are striving to bring awareness to Spinal Muscular Atrophy (SMA), a serious inherited condition caused by changes in the SMN1 gene, which controls motor neurons in the spinal cord and brainstem. Symptoms can begin prior to six months of age, in childhood, or, more rarely, in adulthood. In the most common form […]

Sexually Transmitted Infections and the Pandemic

STIs During the Pandemic Blog

Sexually Transmitted Infections and the Pandemic Since the start of the pandemic, Americans have been told to stay home and remain socially distant to stay healthy. While stay at home orders and quarantine offered protection from COVID-19, they came at a cost to routine health and wellness visits including STI testing. A study published in […]

BioReference Attends White House Coronavirus Task Force

ACLA Statement on COVID-19 Testing STATEMENT FROM ACLA PRESIDENT JULIE KHANI: “We appreciated the opportunity to meet with Vice President Pence and members of the White House’s Coronavirus Task Force this afternoon on the critical issues related to testing capacity. As an industry, clinical labs have taken steps to meet the growing demand for national […]

BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience

Press Release Quote

ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to […]

BioReference Laboratories Selected as Preferred Laboratory Provider by The IPA Association Of America

BioReference to Provide Diagnostic Test Services and Assist with Patient-Centered Data Analytics ELMWOOD PARK, NJ. (August 1, 2019) – BioReference Laboratories, Inc., one of the largest clinical laboratories in the United States, today announced it has been selected by The IPA Association of America (TIPAAA) as its preferred provider of laboratory services and to assist with data […]

BioReference Laboratories Supports Man Cave Health During National Men’s Health Month

Complimentary PSA Testing Provided to Participants of Annual Golf Tournament ELMWOOD PARK, June 7 – BioReference Laboratories, Inc., along with its specialty oncology and urology division, GenPath, announce today their support of Man Cave Health’s upcoming charity golf tournament for Men’s Health Month, observed annually in the United States during the month of June. The event will […]

BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions

ELMWOOD PARK, N.J., May 2, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new research from its prenatal and hereditary cancer assessment programs at the 2019 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting in Nashville, Tennessee from May 3-6. The […]

OPKO’s BioReference Laboratories Selected for UnitedHealthcare’s Preferred Lab Network

ELMWOOD PARK, NJ, April 22, 2019 – BioReference Laboratories Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it will gain preferred laboratory network provider status for UnitedHealthcare. The contract includes BioReference’s subsidiary GeneDx, a full service genetics laboratory.  Learn about the UnitedHealthcare Preferred Lab Network here. “At BioReference we are committed to making […]